Nasus Pharma Ltd (NSRX): Revenue
Figures out of scale. In this company's filings, reported revenue for the year ended 2025-12-31 is more than 100 times total assets. That usually means a value was tagged in the wrong unit. Figures are shown as filed; growth rates are not computed, and the company is left out of screens and comparisons.
$1.24B
Year ended 2025-12-31. As filed; likely tagged in the wrong unit
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.24B | n/a | 2026-03-25, From 2025-01-01 |